期刊文献+

乳腺癌肝转移的机制及治疗 被引量:4

Mechanism and treatment progress of liver metastasis in breast cancer
下载PDF
导出
摘要 乳腺癌是女性最常见的恶性肿瘤,也是女性肿瘤相关性死亡的主要原因。乳腺癌发生远处转移是其死亡的主要原因之一,骨、肺、肝和脑是转移主要的靶器官;肝脏是实体肿瘤常见的转移部位,是乳腺癌第三常见的转移部位。乳腺癌肝转移的过程是多步骤的,是乳腺癌细胞和肝组织微环境中的多种因素共同参与的,进一步了解乳腺癌肝转移的机制对指导临床治疗至关重要。作者论述了乳腺癌肝转移的机制及治疗进展。 Breast cancer is the most common malignancy in women and the leading cause of tumor-related death in women.The main cause of death in patients with breast cancer is metastasis.Bone,lung,liver and brain are the main target organs.Liver is the most common metastatic site of solid tumors and the third most common metastatic site of breast cancer.The process of breast cancer liver metastasis(BCLM)is multi-steps,which is the result of breast cancer cells and microenvironment of liver tissue.Further understanding the mechanisms of BCLM is very important to clinical treatments.This article reviews the mechanisms and clinical treatments of BCLM.
作者 王竞翊 马哿 夏添松 王水 WANG Jingyi;MA Ge;XIA Tiansong;WANG Shui(Department of Breast Surgery, the First Affiliated Hospital with Nanjing Medical University, Nanjing 210029,China)
出处 《中国肿瘤外科杂志》 CAS 2020年第4期375-379,共5页 Chinese Journal of Surgical Oncology
基金 国家自然科学基金面上项目(81572607)。
关键词 乳腺癌 肝转移 机制 治疗 Breast cancer Liver metastasis Mechanism Treatment
  • 相关文献

参考文献1

二级参考文献8

  • 1Rottenberg S, Nygren AO, Pajic M, et al. Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer [ J]. Proc Natl Acad Sci U S A, 2007,104(29) :12117 - 12122.
  • 2Lieder B, Matema V, Schadendorf D, et al. Over-expression of cMOAT(MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to DDP [ J ]. Invest Dermatol,2009,121 ( 1 ) : 172 - 176.
  • 3Van de Vrie W, Marquet RL, Stoter G,et al. In vivo model in P- glycoprotein-mediated multidrug resistance[ J]. Crit Rev Clin Lab Sci,1998,35(1) :1-57.
  • 4Satta T, Isobe K, Yamauchi M, et al. Establishment of drug resist- ance in human gastric and colon carcinoma xenograft lines [ J]. Jpn J Cancer Res,1991,82(2) : 593 -598.
  • 5Ihnat MA,Nervi AM, Anthony SP, et al. Effects of mitomycin C and carboplatin pretreatment on multidrug resistance-associated P-glycoprotein expression and on subsequent suppression of tumor growth by doxorubicin and paclitaxel in human metastatic breast cancer xenografted nude mice [ J ]. Oncol Res, 1999,11 ( 7 ) : 303 -310.
  • 6Filipits M. Mechanisms of cancer: multidrug resistance[ J]. Drug Discov Today : Dis Mech ,2004,1 (2) :229 - 234.
  • 7杨乐,刘文超,李蓉.顺铂水针剂与粉针剂体外细胞毒作用的差异性研究[J].现代肿瘤医学,2008,16(7):1101-1102. 被引量:5
  • 8岑娟,李运曼.多药耐药肿瘤的联合用药[J].国外医药(抗生素分册),2009,30(5):224-228. 被引量:5

共引文献2

同被引文献58

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部